Tony,
I'm not so sure - efficacy in PMS P2 results by extension provides ACAD with a level of confidence their licencing agreement with NEU for NNZ2591 for Fragile X will be a winner
Tony,I'm not so sure - efficacy in PMS P2 results by extension...
-
- There are more pages in this discussion • 1,198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.90 |
Change
-0.060(0.46%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.02 | $12.70 | $823.2K | 64.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 162 | $12.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.90 | 17 | 1 |
View Market Depth
| Last trade - 10.41am 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |